Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Aurobindo Pharma has informed that it has enclosed the compliance certificate for the half year ended 31.03.2020.
The above information is a part of company’s filings submitted to BSE.